Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

dimethylbusulfan

An aliphatic analogue of busulfan with potential antineoplastic activity. As an alkylating agent, dimethylbusulfan induces neutropenia and has been shown to exhibit antitumor effects in some animal models. Alkylating agents exert cytotoxic and chemotherapeutic effects by transferring alkyl groups to DNA, thereby damaging DNA and interfering with DNA synthesis and cell division.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	Dimethyl Myleran Dimethyl-Myleran Dimethylmyleran
Abbreviation:	DMB DMM
NSC code:	180541 180542 180543 23890

dimethylbusulfan

Search NCI's Drug Dictionary